600703:SSESanan Optoelectronics Co., Ltd. Class A Analysis
Data as of 2026-05-28 - not real-time
CN¥16.85
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Sanan Optoelectronics is trading at CNY 16.85, comfortably above its 20‑day (15.85), 50‑day (14.53) and 200‑day (14.54) moving averages, suggesting short‑term price strength, yet the MACD histogram is negative and the signal line is flagged as bearish, indicating momentum is turning lower. The RSI sits at 60, well below overbought levels, while the stock sits midway between a support zone at CNY 13.58 and resistance near CNY 18.04, leaving little upside cushion before hitting the ceiling. Fundamentally, revenue has slumped 32.6% year‑over‑year, margins are thin (gross 9.6%, operating 7.9%) and the trailing EPS is negative (-0.10) despite a forward EPS estimate of 0.31, driving a forward P/E of 54.35 versus the industry average of 40.95. Balance‑sheet stress is evident with total debt of CNY 13.42 bn dwarfing cash of CNY 7.99 bn (debt‑to‑equity 38.3) and a max drawdown of –39% over the recent period. Volatility remains high at 65% over 30 days, but beta is near zero, implying limited market‑wide correlation, and the Fear‑Greed Index is at an “Extreme Greed” 93.3, hinting at possible over‑optimism.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD signal despite price above moving averages
- Proximity to resistance at CNY 18.04 with limited upside
- High short‑term volatility and recent large drawdown
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Forward EPS improvement to 0.31 suggests potential earnings recovery
- Heavy debt load (debt‑to‑equity 38.3) limits financial flexibility
- Semiconductor sector cyclicality may temper price appreciation
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Long‑term demand for optoelectronic components provides structural tailwinds
- Current valuation multiples (forward P/E 54.35, P/B 2.27) are high relative to fundamentals
- Need for deleveraging and margin improvement before sustainable upside
Key Metrics & Analysis
Financial Health
Revenue Growth-32.60%
Profit Margin-3.01%
P/E Ratio54.4
ROE-1.33%
ROA-0.42%
Debt/Equity38.31
P/B Ratio2.3
Op. Cash FlowCN¥1.6B
Free Cash FlowCN¥665.0M
Industry P/E40.9
Technical Analysis
TrendNeutral
RSI60.0
SupportCN¥13.58
ResistanceCN¥18.04
MA 20CN¥15.85
MA 50CN¥14.53
MA 200CN¥14.54
MACDBearish
VolumeStable
Fear & Greed Index93.32
Valuation
Fair ValueCN¥0.67
GradeOvervalued
TypeValue
Dividend Yield0.12%
Risk Assessment
Beta-0.09
Volatility65.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.